IDEAYA Biosciences Inc (IDYA)
26.79
+0.19
(+0.71%)
USD |
NASDAQ |
Nov 22, 16:00
26.77
-0.02
(-0.07%)
Pre-Market: 20:00
IDEAYA Biosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -865.8% |
| September 30, 2023 | -341.4% |
| June 30, 2023 | -788.0% |
| March 31, 2023 | -281.4% |
| December 31, 2022 | -601.7% |
| September 30, 2022 | 5.44% |
| June 30, 2022 | -377.0% |
| Date | Value |
|---|---|
| March 31, 2022 | -123.4% |
| December 31, 2021 | -614.9% |
| September 30, 2021 | -129.0% |
| June 30, 2021 | -125.0% |
| March 31, 2021 | -124.6% |
| December 31, 2020 | -48.58% |
| September 30, 2020 | -54.93% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-865.8%
Minimum
Dec 2023
5.44%
Maximum
Sep 2022
-319.3%
Average
-205.2%
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences Inc | 16.61% |
| Vertex Pharmaceuticals Inc | 37.71% |
| Black Diamond Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |